Source: Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Laurent Savale, Christophe Guignabert, Jason Weatherald, Marc Humbert. Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era. Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension: combination therapy in the modern management era Source: Eur Respir Rev 2010 19: 348-349 Year: 2010 Facing a new era: how does the pandemic change sleep medicine and practice? Source: Sleep and Breathing Conference 2021 Year: 2021 Precision medicine in COPD: where are we and where do we need to go? Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018 Year: 2018 Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Precision medicine in airway diseases: moving to clinical practice Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017 Year: 2017 Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014 In the era of personalized medicine, what are the current unmet needs in asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019 Epigenetics and pulmonary diseases in the horizon of precision medicine: a review Source: Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020 Year: 2021 Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future? Source: Eur Respir J, 53 (6) 1900583; 10.1183/13993003.00583-2019 Year: 2019 Pulmonary arterial hypertension: tailoring treatment to risk in the current era Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017 Year: 2017 The new era of diagnostics: will it ever start? Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship Year: 2019 Precision medicine in tuberculosis treatment – a role for pharmacogenetics? Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018 Pregnancy outcomes in pulmonary arterial hypertension in the modern management era Source: Eur Respir J 2012; 40: 1304-1305 Year: 2012 Medical therapy for COPD: lessons from the real world Source: Eur Respir J 2002; 20: 797-798 Year: 2002 Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers Source: Eur Respir J 2005; 25: 397-399 Year: 2005 Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances? Source: Eur Respir J 2016; 47: 388-389 Year: 2016 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation? Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet? Source: Eur Respir Rev 2014; 23: 458-468 Year: 2014